Abstract

Background: The abuse of methamphetamine (MA) worldwide has gained international attention as the most rapidly growing illicit drug problem. The classification and treatment response prediction of MA addicts are thereby paramount, in order for effective treatments to be more targeted to individuals. However, there has been limited progress.Methods: In the present study, 43 MA-dependent participants and 38 age- and gender-matched healthy controls were enrolled, and their resting-state functional magnetic resonance imaging data were collected. MA-dependent participants who showed 50% reduction in craving were defined as responders to treatment. The present study used the machine learning method, which is a support vector machine (SVM), to detect the most relevant features for discriminating and predicting the treatment response for MA-dependent participants based on the features extracted from the functional graph metrics.Results: A classifier was able to differentiate MA-dependent subjects from normal controls, with a cross-validated prediction accuracy, sensitivity, and specificity of 73.2% [95% confidence interval (CI) = 71.23–74.17%), 66.05% (95% CI = 63.06–69.04%), and 80.35% (95% CI = 77.77–82.93%), respectively, at the individual level. The most accurate combination of classifier features included the nodal efficiency in the right middle temporal gyrus and the community index in the left precentral gyrus and cuneus. Between these two, the community index in the left precentral gyrus had the highest importance. In addition, the classification performance of the other classifier used to predict the treatment response of MA-dependent subjects had an accuracy, sensitivity, and specificity of 71.2% (95% CI = 69.28–73.12%), 86.75% (95% CI = 84.48–88.92%), and 55.65% (95% CI = 52.61–58.79%), respectively, at the individual level. Furthermore, the most accurate combination of classifier features included the nodal clustering coefficient in the right orbital part of the superior frontal gyrus, the nodal local efficiency in the right orbital part of the superior frontal gyrus, and the right triangular part of the inferior frontal gyrus and right temporal pole of middle temporal gyrus. Among these, the nodal local efficiency in the right temporal pole of the middle temporal gyrus had the highest feature importance.Conclusion: The present study identified the most relevant features of MA addiction and treatment based on SVMs and the features extracted from the graph metrics and provided possible biomarkers to differentiate and predict the treatment response for MA-dependent patients. The brain regions involved in the best combinations should be given close attention during the treatment of MA.

Highlights

  • Abuse of the synthetic psychostimulant, methamphetamine (MA), has gained international attention as the most rapidly growing illicit drug problem worldwide [1]

  • Through the stepwise removal of the top features, the investigators were able to arrive at an optimal combination, which identified patients in 73.2% [95% confidence interval (CI) = 71.23–74.17%] of the cases (Table 3A)

  • The most accurate combination of classifier features included the nodal efficiency in the right middle temporal gyrus (MTG.R), and the community index in the left precentral gyrus (PreCG.L) and cuneus (CUN.L), in which the community index in PreCG.L had the highest importance

Read more

Summary

Introduction

Abuse of the synthetic psychostimulant, methamphetamine (MA), has gained international attention as the most rapidly growing illicit drug problem worldwide [1]. MA abuse is usually accompanied by various health consequences, such as depression, anxiety, psychosis, cardiovascular disease, and human immunodeficiency virus, hepatitis B virus, hepatitis C virus that are spread by blood and sex behaviors due to the social environmental factor of MA use. The MA-induced harm on CNS further results in significant psychiatric withdrawal symptoms. Typical psychiatric symptoms include persecutory delusions, auditory hallucinations, and loss of insight that difficultly distinguish from some mental illnesses such as schizophrenia, and MA-induced withdrawal symptoms usually include anhedonia, hypersomnia, irritability, anxiety, aggression, and intense cravings for MA [5, 6]. The abuse of methamphetamine (MA) worldwide has gained international attention as the most rapidly growing illicit drug problem.

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call